Amgen Inc. (AMGN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Amgen Inc. (AMGN)

An SI Board Since December 1996

Posts	SubjectMarks	Bans	Symbol
1906	112	0	AMGN

Emcee: trevor john wilkinson	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1381	Is that you Warren?	tom pope	-	2/17/2007
1380	If you see a spike in the volume Tuesday morning its me. I'm gone.	SirWalterRalegh	-	2/17/2007
1379	Thanks, Tom, It's been tough to watch the decline since earnings. Yesterda	tuck	-	2/17/2007
1378	ML: Case Against Aranesp Builds; But Risk in Stock Data from a new study using	tom pope	-	2/17/2007
1377	I thought there was a second one. Here it is. This drug seems to block cancer ce	JGoren	-	2/7/2007
1376	Sounds like it. Thanks for the input. All I had heard was a radio report, which	JGoren	-	2/7/2007
1375	Are you referring to this one? Message 23256118 Don't get your shorts in a	tuck	-	2/6/2007
1374	Does anyone have information on the research for that new drug that kills cancer	JGoren	-	2/6/2007
1373	Does anyone have information on the research for that new drug that kills cancer	JGoren	-	2/6/2007
1372	>>Court Rules For Amgen In Enbrel-Related Patent Suit 01/30/2007 Dow Jon	tuck	-	1/30/2007
1371	thx.	kenhott	-	1/29/2007
1370	Merrill: Dear Doctor letter issued on Aranesp mortality data Amgen issued a Dea	tom pope	-	1/29/2007
1369	Earnings color from TheStreet.com's Marc Lichtenfeld (formerly of Avalon, bu	tuck	-	1/26/2007
1368	Merrill: Guidance reflects uncertainty in ’07 vs ‘06 We believe conservative ‘0	tom pope	-	1/26/2007
1367	Amgen Net Rises, But CEO Girds For Tough '07 [WSJ] By MARILYN CHASE January	Doc Bones	-	1/26/2007
1366	<i>Does that mean that Vectibix is over?</i> Vectibix is here to st	DewDiligence_on_SI	-	1/25/2007
1365	Does that mean that Vectibix is over?	steve kammerer	-	1/25/2007
1364	Vectibix PACCE trial: We can be reasonably sure that, in the preliminary look at	DewDiligence_on_SI	-	1/25/2007
1363	R & D expense went up large. Probably 20 cents worth of potential earnings.	BWAC	-	1/25/2007
1362	Amgen missed despite beating (slightly) on revenues. Expenses must have been hi	tuck	-	1/25/2007
1361	I still think Amgen filed the documents. The detail that got the analyst's a	JGoren	-	1/25/2007
1360	I don't know for sure; I think it was Amgen. If I knew which court the case	JGoren	-	1/24/2007
1359	Oh? Do you know who filed the cited documents? If it was Amgen, I doubt the an	tuck	-	1/24/2007
1358	The patent thing was bound to be short lived, because any real resolution is sti	JGoren	-	1/24/2007
1357	Ah, the reason for the weakness comes from a call by FBR concerning the implicat	tuck	-	1/24/2007

Go to reply# or date (mm/dd/yy):